Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
A system using $30 WiFi sensing modules that monitors elderly residents' daily patterns (movement, sleep, falls, routine adherence) through walls without cameras or wearables, alerting family members and caregivers to health decline signals.
Kill Reason
Amazon Alexa Together and comparable remote family monitoring services already serve this exact use case at consumer price points with embedded distribution advantages that a standalone WiFi sensing module cannot overcome. Daily routine monitoring and anomaly alerting for elderly relatives is a feature, not a product, in the current competitive landscape.
What do you think?
Related ideas you can explore free:
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.
killed: Personal injury narrative reports require specific medico-legal structure, but the format is well-documented in public templates and any chiropractor with a configured AI prompt can replicate the output — there is no proprietary data asset, workflow lock-in, or network effect to justify a subscription fee against a commodity capability.
killed: The FDA approval barrier for health screening claims is prohibitive for a startup — without regulatory clearance, the product must avoid medical language, which hollows out the core value proposition. Apple and Google are building voice and sensor health monitoring directly into their platforms, and they have the regulatory resources to navigate FDA that a startup cannot match.